Transforming Weight Loss in the Digital Age: A $260.6 Billion Challenge

Finding: Medications taken by Medisafe users for obesity has doubled

By Stacey Wasserman
Chief Business Officer

Stacey Wasserman

Stacey Wasserman, Medisafe Chief Business Officer

Weight management is a global concern affecting 650 million people, with four million annual deaths attributed to obesity, according to the World Health Organization. In the United States alone, the annual cost of obesity-related medical care was estimated at nearly $260.6 billion. Addressing this challenge requires innovative solutions, and the intersection of weight management and digital health is proving to be a game-changer.

The Role of Digital Health in Weight Management

For individuals with a body mass index (BMI) over 25, and particularly those exceeding 30, obesity becomes a significant health concern. Enter digital health, a realm of innovative solutions that can effectively aid people in managing their weight. Among these, Medisafe stands out, demonstrating its ability to enhance patient outcomes while reducing annual patient costs and medical claims.

Medisafe Users’ Top 5 Medications for Weight Control

Medisafe users managing weight have identified five key medications for effective weight control: Wegovy, Phentermine, Saxenda, Contrave, and Ozempic. Of these, Wegovy and Ozempic, both Semaglutide anti-obesity medications, have seen a substantial increase in popularity. Real-world data analysis reveals that Medisafe users on Semaglutide medications exhibit higher adherence and better treatment results compared to users on other anti-obesity drugs.

The Impact of Semaglutide Medications

In the last five years, the popularity of medications taken by Medisafe users for obesity has doubled, primarily driven by Semaglutide medications like Wegovy and Ozempic. Notably, these medications haven’t replaced other anti-obesity drugs; instead, they have added a new population of patients to those using medications for weight control.

Patients using Semaglutide medications for weight management reported, on average, higher weight loss compared to those on Phentermine-based drugs. While starting from a higher initial weight, the Semaglutide group showcased greater adherence, with a demographic skew toward more men and adults aged 46-65.

Patient Survey Insights

A January 2024 patient survey conducted within the Medisafe app revealed that most patients undergoing anti-obesity treatment reported a substantial weight loss, regardless of whether they were on Phentermine or Semaglutide-based medications. However, Semaglutide patients reported higher weight loss, likely due to their starting from a higher initial weight.

While there was no statistically significant difference in perceived treatment effect between Phentermine and Semaglutide groups, the survey did highlight a significant difference in reported adverse side effects. Almost half of Semaglutide patients reported experiencing some bothersome side effects, indicating the need for careful monitoring and management.

Comorbidities and Holistic Health

Understanding the broader context, co-morbidities with weight management are prevalent, with depression, hypertension, and anxiety being the top three. This emphasizes the need for a comprehensive approach to healthcare that goes beyond medication alone.

The Importance of Patient Journey Engagement for GLP-1 Medication Users

While Medisafe has proven instrumental in weight management, its significance extends to patients taking GLP-1 medications as well. For those using GLP-1 medications like Semaglutide, a medication tracker becomes a crucial tool for several reasons.

Enhanced Adherence and Improved Outcomes

A medication tracker supports patients in adhering to their prescribed GLP-1 medication regimen, contributing to the medication’s effectiveness in managing conditions like type 2 diabetes. The real-time data generated by the tracker enables healthcare providers to intervene promptly, leading to improved patient outcomes and better disease management.

Personalized and Holistic Health Monitoring

Weight Loss data from Medisafe

Source for full report:

Medication trackers, integrating with broader health tracking features, provide a comprehensive view of the patient’s health. This holistic approach enables personalized care, taking into account lifestyle factors, comorbidities, and medication adherence.

Empowering Patients and Preventing Errors

Medication trackers empower patients to actively participate in their healthcare journey, fostering a sense of control and confidence. Additionally, the tracker serves as a preventive tool, minimizing the risk of medication errors in dosage or administration.

Facilitating Communication and Collaboration

By facilitating communication and collaboration between patients and healthcare providers, a medication tracker ensures transparent and effective discussions during consultations. Shared data supports shared decision-making, enhancing the overall patient experience.

The fusion of weight management, digital health, and innovative tools like Medisafe is reshaping patient care plans. As we navigate the $260.6 billion challenge of obesity, these solutions not only improve outcomes and reduce costs but also empower patients to take control of their health journey. Digital health, embodied by platforms like Medisafe, is not just a part of patient care plans; it’s an indispensable partner in the pursuit of healthier lives worldwide. Medisafe, a Connected Health Experience, emerges as a transformative tool in patient care plans, delivering improved outcomes and reducing costs.

You may also like

Webinar Recording: Doing Digital Right – What Patients Really Want from Pharma

Patients are feeling empowered by digital health solutions, and a survey by Medisafe shows that Pfizer, Abbott, Astra Zeneca, and 

..Read More

New Analysis Shows Reduction in Annual Patient Costs and Medical Claims with Medisafe

BOSTON – Medisafe, a leading digital health company specializing in medication engagement, released the results of a new retrospective, pre- 

..Read More
Case Studies

Medisafe Discovers Mismanagement of Leading Asthma Medication

Medisafe data shows that more than 25% of patients who take a leading asthma medication do so in the morning. 

..Read More

Want to Learn More?

We bring decades of experience to your challenges—and technology and solutions uniquely designed to meet your needs.